Amyloidosis

A. SAA, AA and AP Proteins.- Protein AA and Associated Proteins in Type-AA Amyloid Substance.- Heterogeneity of Human Amyloid Protein AA and SAA.- Vascular AA Amyloidosis is Characterized by Special Protein AA Subspecies.- The Physico-Chemical, Antigenic and Functional Heterogeneity of Human Serum Amyloid A.- Reaggregation of Bovine Amyloid A Fibril Components to ?-Pleated Sheet Fibrillar Structures.- Analysis of X-Ray Scattering by Human AA Fibrils using Secondary Structure Predictions of Human SAA1.- Characterization of Two Distinct Serum Amyloid A Gene Products Defined by Their Complementary DNAs.- Human Serum Amyloid Genes — Molecular Characterization.- Kinetics of Human Serum Amyloid A.- Ultrastructural Identification of AA-Type Amyloid Fibrils Using Polyclonal and Monoclonal Antibodies.- Human Serum Amyloid P-Component (SAP) as an Acute Phase Reactant in the Female.- B. Experimental Models.- Pathogenetic Mechanisms and Precursor Product Relationships in Murine Amyloidosis.- A Possible Effect of Oral Tolerance in Casein Induced Murine Amyloidosis?.- Isolation and Characterization of Amyloid Enhancing Factor (AEF).- Enhancement of Amyloid Degradation by Ascorbic Acid: In Vivo Evidence in a Murine Model.- Effect of Colchicine on the Acute Phase Serum Amyloid A Protein Response and Splenic Amyloid Deposition During Experimental Murine Inflammation.- Serum Amyloid A Protein (SAA) from Mink, Horse, and Man: A Comparative Study.- The Time Relationship Between Amyloid Deposition and Glycosaminoglycan Accumulation During Experimental Amyloidosis.- Kinetics of Selective Deposition of ApoSAA2 During Development of Amyloidosis in Mice.- InVivo Radioimmunodetection of Amyloid Deposits in Experimental Amyloidosis.- Prostacyclin and Thromboxane Production from Macrophages of Amyloid Resistant and Sensitive Mice.- C. In Vitro Synthesis.- Regulation of Serum Amyloid A Synthesis in Primary Mouse Hepatocyte Cultures.- Immunoelectron Microscopic Study of Liver in Experimental Murine Amyloidosis Using Anti-Mouse AA Antiserum.- Immunocytochemical Studies on the Site of Synthesis and Pathways of Amyloid Protein AA.- A Comparison of Serum Amyloid A (SAA) Synthesis With That of the Pentraxins: Serum Amyloid P (SAP) and C-Reactive Protein (CRP).- Further Studies on the Mechanism of Action of Surface Associated Proteolytic Enzymes on Lymphocytes and Monocytes Which Degrade SAA Precursor to AA-Like Products.- Down-Regulation of Kupffer Cell Ectoenzymes Precedes Deposition of Amyloid Protein A.- Specific Chemical Dissociation of Fibrillar and Non-Fibrillar Components of Amyloid Deposits.- D. Degrading Factors.- Degradation of AA-Amyloid, Clinical Experience: An Introduction.- In Vivo Degradation of Protein SAA to Protein AA and Incorporation in Amyloid Fibrils.- Isolation and Characterization of the Inhibitor of Amyloid Degrading Factor.- Amyloid-Agarose Plate Test: Ultrastructural Changes in the Fibril and Its Association with Human Neutrophil Elastase.- Decreased Esterase Activity in Serum of Patients with Reactive Systemic (AA) Amyloidosis.- Enhanced Degradation of Amyloid AA Proteins by Enzyme Activation: A Possible Model for a Therapeutic Approach.- Does Serum Degrade Amyloid Fibrils? Failure to Confirm Enzymatic Degradation of Amyloid A Fibrils as the Basis of the So-Called “Amyloid Degrading Activity” of Serum.- E. Hereditary and Familial (AF) Amyloidosis.- Statement Regarding Nomenclature for the Protein Known as Prealbumin, Which is Also (Recently) Called Transthyretin.- Family Studies of Transthyretin (Prealbumin) and Its Methionine 30 Variant in Portuguese Patients with Familial Amyloidotic Polyneuropathy.- Serum Concentrations of Prealbumin and Retinol Binding Protein in Familial Amyloid Patients From 15 Kinships.- Pre-Albumin and Retinol Binding Protein Serum Concentrations in the Brazilian Type (Portuguese) of Familial Polyneuropathy.- Clinical Investigations of Autonomic Heart Regulation and Renal Function of Familial Amyloidotic Polyneuropathy.- Identification of Amyloid Prealbumin Variant in Familial Amyloidotic Polyneuropathy of Japanese Origin: Three Patients of Different Pedigrees.- Monoclonal Antibodies to Serum Prealbumin of a Patient with Familial Amyloidotic Polyneuropathy.- Salient Structural Features of Low Molecular Weight Amyloid Fibril Proteins in Familial Amyloid Polyneuropathy of Japanese Origin.- Immunohistochemical Studies on Autopsied Organs of Familial Amyloid Polyneuropathy in Relation with Amyloid Protein.- Studies on Blood Markers and Amyloid Fibril in the Arao Focus of Familial Amyloid Polyneuropathy.- Familial Amyloidotic Polyneuropathy Type I and Type II: Characterization of Two Distinct Genetic Defects and Identification of Carriers of Each Gene.- Familial Amyloidotic Polyneuropathy Type I: Characterization of the Prealbumin Amyloid Subunit and Precursor Protein.- Immonohistochemical Studies on Hereditary Amyloidosis of the Finnish Type.- Late Onset Hereditary Amyloidosis in a Family from Texas.- Genetic Heterogeneity of Familial Amyloid Polyneuropathies of Jewish Type.- Prealbumin Nature of the Amyloid in Familal Amyloid Cardiomyopathy of Danish Origin.- Diagnosis of Familial Amyloidotic Polyneuropathy by Recombinant DNA Techniques.- Biochemical Nature of Familial Amyloidotic Polyneuropathy and a New Diagnostic Method by Radioimmunoassay.- Clinical and Pathological Studies of Familial Amyloid Polyneuropathy (FAP), with Special Reference to Nephropathy and Cardiopathy.- Cardiac Disorders and Autonomic Nervous System Involvement in Familial Amyloidosis.- Treatment of Orthostatic Hypotension in Familial Amyloid Polyneuropathy with L-Threo-3,4-Dihydroxyphenylserine.- Review of Clinical Records and Therapeutic Trials in Familial Amyloidotic Polyneuropathy (Type I) in Japan.- F. Immunoglobuin (AL) Amyloidosis.- Light Chain Variable Region Subgroups of Monoclonal Immunoglobulins in Amyloidosis AL.- Structural Studies of the Variable Region of Immunoglobulin Light-Chain-Type Amyloid Fibril Proteins.- Amyloidogenicity and Subgroups of Human Lambda Bence Jones Proteins.- Appearance of Systemic Amyloidosis in Myeloma with Amyloidogenic Bence Jones Protein.- Complete Primary Structure of an Immunoglobulin ?II-Chain Derived Amyloid Fibril Protein (HAR).- Some Structural Factors Involved in Amyloid Fibril Formation by Lambda VI Light Chain Proteins.- Polymorphism in a Kappa I Primary (AL) Amyloid Protein (Ban).- Analysis of Monoclonal Components in Systemic AL-Amyloidosis.- Structural and Immunologic Studies of a Kappa Amyloid Fibril Protein.- Molecular Heterogeneity and ?-Carboxyglutamic Acid Content of Bence-Jones Proteins: Possible Relevance to Amyloidogenicity.- Aberrant Immunoglobulin Synthesis in AL Amyloid.- G. Clinical Studies.- Primary Systemic Amyloidosis (AL): Comparison of Melphalan-Prednisone vs. Colchicine Treatment in 101 Cases.- The Life Span of Patients with Primary (AL) Amyloidosis and the Effect of Colchicine Treatment.- The Impact of Colchicine on the Amyloidosis of Familial Mediterranean Fever (FMF).- Treatment of Systemic AA Amyloidosis.- Splenic Function in Amyloidosis.- Does the Urinary Protein Pattern in AA-Amyloid Nephropathy Differ From That in Other Nephropathies?.- Classification of Amyloid Syndromes from Tissue Sections Using Antibodies Against Various Amyloid Fibril Proteins: Report of 142 Cases.- Clinical, Pathological, and Functional Findings in Amyloid Nephropathy.- Fine Needle Aspiration Biopsy of Abdominal Subcutaneous Fat Tissue for the Diagnosis and Typing of Amyloidosis.- Non-Invasive Techniques for Demonstrating Cardiac Involvement in the Acquired Forms of Systemic Amyloidosis.- Soft-Tissue Uptake of 99mTc-Disphosphonate and 99mTc-Pyrophosphate in Systemic AA and AL-Amyloidosis.- Plasma Exchange in the Treatment of Patients with Systemic Amyloidosis.- H. Aging and Amyloidosis.- Research in Aging and Amyloidosis.- Amyloid and Aging — An Hypothesis Involving So-Called Amyloid Degrading Activity (ADA).- Senile Systemic Amyloidosis.- Varied Composition and Nature of Senile Localized Amyloid: Implications for Varied Mechanisms of Pathogenesis.- A New Senile Amyloid Fibril Protein and Its Putative Precursor in Senescence Acclerated Mouse (SAM).- Amyloid Deposition in the Articular Structures of Senescence Accelerated Mouse (SAM).- Antioxidants in Experimental Amyloidosis of Young and Old Mice.- I. Cerebral Amyloidosis and Alzheimer’s Disease.- Amyloid Research as a Paradigm for Alzheimer’s Disease.- Neurobiological Probes for Specific Constituents of Senile Plaques in Aging and Alzheimer’s Disease.- Biochemical and Structural Studies of Paired Helical Filaments and Senile Plaque Amyloid in Alzheimer’s Disease.- Alzheimer Neurofibrillary Tangle and Its Relationship with Plaque Core Amyloid.- Cerebral Amyloid and Alzheimer’s Syndrome.- Prion Amyloids in Scrapie and Creutzfeldt-Jakob Disease.- Senile Cerebral Amyloid — Evidence for a Neuronal Origin of the Fibril Protein.- Isolation and Partial Characterization of Alzheimer Neurofibrillary Tangles.- Amylid Fibrils in Hereditary Cerebral Hemorrhage with Amyloidosis (HCHWA) is Related to Cystatin (Gamma Trace).- Cerebral Amyloid Angiopathy Causing Intracranial Hemorrhage, A Clinicopathological Study of 12 Cases.- The Role of Cerebral Amyloid Angiopathy in Dementia of Alzheimer’s Type (Preliminary Results).- Hereditary Central Nervous System ?- Trace Amyloid Angiopathy and Stroke in Icelandic Families.- J. Other Types of Amyloidosis.- Amyloid Associated with Calcifying Epithelial Odontogenic Tumor — A New Type of Amyloid Fibril Protein CEOT.- Immunological Homology of the Amyloid of Insulinoma and the Islet Amyloid of the Aged: Biochemical Characterization of the Insulinoma Amyloid.- Histopathology of the Cutaneous Amyloid: A Comparative Study on 144 Cases of Localized Cutaneous Amyloidosis and 20 Cases of Systemic Amyloidosis.- Histological Evidence of Amyloid Deposition in Old Thrombotic Lesions and in Longterm Bioprosthetic Cardiac Valve Implants in Man: Two Recently Observed and Possibly Related Forms of Localized Amyloidosis of the Cardiovascular System.- Contributors.